Home/ Stocks/ MTNB

Matinas BioPharma Holdings, Inc.

MTNB XASE

$0.28 -0.00 (-0.52%) ▼ 15-min delayed

Open

$0.26

High

$0.28

Low

$0.25

Volume

1.15M

Market Cap

$1.72M

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-1,921,000	$-0.30
FY 2025	$0	$-10,345,000	$-2.00
Q3 2025	$0	$-1,532,000	$-0.40
Q2 2025	$0	$-5,245,000	$-1.03

Related Market News

No specific coverage for MTNB yet. Check out our latest market news or earnings calendar.

Get MTNB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Matinas BioPharma Holdings, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.